Locations
Rotterdam, Netherlands · South Holland, Netherlands
industry
Biotechnology
Size
11-50 employees
Stage
Series A
founded in
2018
Enabling more for less. It's our mission to make label-free, multiplexed biosensing accessible to all. Assay developers need to validate next-gen biomarker panels for more accurate diagnostics. Academic researchers need to extract more data from precious samples to guide their studies. Pharma scientists need to speed up drug development by collecting extensive data from a wide range of samples. The merits of label-free biosensing? Label-free biosensing enables real-time, direct detection without the need for tagging target molecules. This revolutionary approach benefits a wide range of applications, from studying molecular interactions and accelerating drug kinetics-screening to selecting high-quality antibodies based on kinetics and developing real-time quantitative biomarker assays. Most platforms focus on one aspect—sensitivity, multiplexing, or cost. Researchers need all three. And the high costs mean it's only accessible for big-budget labs.
Is this your company?
Something looks off?
On-site & Remote